drugset / Trial / NCT00802100
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will compare the safety and effectiveness of three different antipsychotic medications, as well as the use of other medications to limit treatment side effects, in adults with schizophrenia.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-09
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 30 mg | Oral |
| Subject | Olanzapine | Small molecule | 30 mg | Oral |
| Subject | Perphenazine | Small molecule | 24 mg | Oral |
| Background | Benztropine | Small molecule | 2 mg | Oral |
| Background | Metformin | Small molecule | 2550 mg | Oral |
| Background | Simvastatin | Small molecule | 40 mg | Oral |